If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoldstone Resources Share News (GRL)

  • This share is currently suspended. It was suspended at a price of 2.15

Share Price Information for Goldstone Resources (GRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.15
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.15
GRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Faron Pharmaceuticals raises EUR12 million

Fri, 27th Jan 2023 10:11

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Inspecs Group PLC, up 15% at 108.00 pence, 12-month range 38.50p-400p. The Bath, England-based eyewear company extends rally from Thursday. On Thursday, Inspecs said full-year trading was in line with expectations, despite Covid-19 restrictions in China and Vietnam. The company predicted revenue for 2022 to be USD246.0 million, flat from USD246.5 million in 2021. It said on a constant exchange rate basis, revenue increased by 9.5%. Looking ahead, Inspecs said it has entered 2023 with a good order book, and it hopes to continue to seek operational efficiencies and reduce costs where appropriate.

----------

AIM - LOSERS

----------

Faron Pharmaceuticals Ltd, down 5.9% at 319.80p, 12-month range 155p-395p. The biopharmaceutical company raises EUR12.0 million from a placing of 3.7 million shares at the issue price of EUR3.25. Faron says that with these proceeds and the current level of activity, it has sufficient working capital into the third quarter of 2023. The main reason for the placing is to accelerate and expand the clinical development of the company's main drug candidate, bexmarilimab.

----------

Goldstone Resources Ltd, down 8.3% at 3.53p, 12-month range 3p-10.75p. The Jersey, UK-based gold development company issues GBP2.4 million of convertible loan notes to Blue Gold International Ltd, which are due for redemption on November 30, 2023. The notes may be converted at any time prior to redemption into new ordinary shares of 1p each in the capital of the Goldstone at a conversion price of GBP0.0325 per share. BGL also receives warrants to subscribe for up to 60.0 million shares at a price of GBP0.04 per share, at any time until January 26, 2025.

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.